<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pedersen CN</submitter><funding>Aarhus Universitets Forskningsfond</funding><funding>NIDA NIH HHS</funding><funding>Danish Ministry for Research and Higher Education</funding><funding>NIMH NIH HHS</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>Novo Nordisk Fonden</funding><funding>Lundbeck Foundation</funding><funding>NIH HHS</funding><pagination>2043-2055</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11449642</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>168(9)</volume><pubmed_abstract>The regulation of dopamine (DA) removal from the synaptic cleft is a crucial process in neurotransmission and is facilitated by the sodium- and chloride-coupled dopamine transporter DAT. Psychostimulant drugs, cocaine, and amphetamine, both block the uptake of DA, while amphetamine also triggers the release of DA. As a result, they prolong or even amplify neurotransmitter signaling. Atypical inhibitors of DAT lack cocaine-like rewarding effects and offer a promising strategy for the treatment of drug use disorders. Here, we present the 3.2 Å resolution cryo-electron microscopy structure of the Drosophila melanogaster dopamine transporter (dDAT) in complex with the atypical non-competitive inhibitor AC-4-248. The inhibitor partially binds at the central binding site, extending into the extr</pubmed_abstract><journal>Journal of neurochemistry</journal><pubmed_title>Cryo-EM structure of the dopamine transporter with a novel atypical non-competitive inhibitor bound to the orthosteric site.</pubmed_title><pmcid>PMC11449642</pmcid><funding_grant_id>P30 CA010815-53</funding_grant_id><funding_grant_id>R01 DA051205</funding_grant_id><funding_grant_id>AUFF‐E‐2022‐9‐24</funding_grant_id><funding_grant_id>NNF19OC0054875</funding_grant_id><funding_grant_id>R310‐2018‐3713</funding_grant_id><funding_grant_id>R01 DA051205-03</funding_grant_id><funding_grant_id>P30 CA010815</funding_grant_id><funding_grant_id>S10OD030245-01</funding_grant_id><funding_grant_id>R346-2020-1944</funding_grant_id><funding_grant_id>MH106912</funding_grant_id><funding_grant_id>R01 DA051205‐03</funding_grant_id><funding_grant_id>S10 OD030245</funding_grant_id><funding_grant_id>MH121453</funding_grant_id><funding_grant_id>5072-00025B</funding_grant_id><funding_grant_id>NNF18OC0032608</funding_grant_id><funding_grant_id>R01 MH106912</funding_grant_id><funding_grant_id>R56 MH121453</funding_grant_id><funding_grant_id>P30 CA010815‐53</funding_grant_id><funding_grant_id>S10OD030245‐01</funding_grant_id><funding_grant_id>R310-2018-3713</funding_grant_id><funding_grant_id>NNF18OC0054875</funding_grant_id><funding_grant_id>AUFF-E-2022-9-24</funding_grant_id><funding_grant_id>R368-2021-522</funding_grant_id><funding_grant_id>R368‐2021‐522</funding_grant_id><pubmed_authors>Pedersen CN</pubmed_authors><pubmed_authors>Neumann CMT</pubmed_authors><pubmed_authors>Desdorf LM</pubmed_authors><pubmed_authors>Akunuri R</pubmed_authors><pubmed_authors>Mortensen OV</pubmed_authors><pubmed_authors>Schiott B</pubmed_authors><pubmed_authors>Yang F</pubmed_authors><pubmed_authors>Ita S</pubmed_authors><pubmed_authors>Trampari S</pubmed_authors><pubmed_authors>Salvino JM</pubmed_authors><pubmed_authors>Shahsavar A</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors><pubmed_authors>Nissen P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cryo-EM structure of the dopamine transporter with a novel atypical non-competitive inhibitor bound to the orthosteric site.</name><description>The regulation of dopamine (DA) removal from the synaptic cleft is a crucial process in neurotransmission and is facilitated by the sodium- and chloride-coupled dopamine transporter DAT. Psychostimulant drugs, cocaine, and amphetamine, both block the uptake of DA, while amphetamine also triggers the release of DA. As a result, they prolong or even amplify neurotransmitter signaling. Atypical inhibitors of DAT lack cocaine-like rewarding effects and offer a promising strategy for the treatment of drug use disorders. Here, we present the 3.2 Å resolution cryo-electron microscopy structure of the Drosophila melanogaster dopamine transporter (dDAT) in complex with the atypical non-competitive inhibitor AC-4-248. The inhibitor partially binds at the central binding site, extending into the extr</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2026-05-29T11:34:19.236Z</modification><creation>2026-04-08T04:30:13.681Z</creation></dates><accession>S-EPMC11449642</accession><cross_references><pubmed>39010681</pubmed><doi>10.1111/jnc.16179</doi></cross_references></HashMap>